Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

Patient care at the Cancer Institute Lucien Neuwirth
Patient aged over 18 years
Patient with breast cancer overexpressing HER2 adjuvant
Patient having finished their chemotherapy treatment with IV followed the oncologist day hospital
Patient under Trastzumab subcutaneously
Patient affiliated or entitled to a social security scheme (mandatory requirement for all studies)

Feasibility Assessment of a Patients Follow-up Visit Receiving Trastuzumab Subcutaneous by Advanced Practice Nurse